The UK Health Security Agency (UKHSA) publishes a recurring series of epidemiological commentaries drawing on mandatory surveillance data for healthcare-associated infections (HCAIs) in England. The most recent release covers the period January to March 2027, continuing an established framework of official reporting on pathogens that pose persistent risks within clinical settings.
What the Surveillance Covers
According to the UKHSA, the quarterly commentary examines four principal infection categories: methicillin-resistant Staphylococcus aureus (MRSA), methicillin-sensitive Staphylococcus aureus (MSSA), Gram-negative bacteraemia, and Clostridioides difficile (C. difficile) infection.
Within the Gram-negative bacteraemia category, the agency tracks three specific organisms: Escherichia coli (E. coli), Pseudomonas aeruginosa, and Klebsiella species. Each of these pathogens is associated with bloodstream infections that can be difficult to treat, particularly where antimicrobial resistance is a factor.
Mandatory Reporting Framework
The data underpinning the commentary is gathered through a mandatory reporting structure, meaning healthcare providers in England are required to submit infection data to the agency on an ongoing basis. The UKHSA then analyses epidemiological trends across the covered pathogens and publishes the findings as accredited official statistics.
This classification — accredited official statistics — indicates the data meets standards set by the Office for Statistics Regulation, lending the figures a degree of methodological transparency and consistency across reporting periods.
Why These Pathogens Are Monitored
MRSA and MSSA are both strains of Staphylococcus aureus, a bacterium capable of causing serious bloodstream infections. MRSA is of particular concern due to its resistance to a range of commonly used antibiotics, making infections harder to manage in hospital environments.
Gram-negative bacteria such as E. coli and Klebsiella species are among the leading causes of bloodstream infections in healthcare settings globally. Pseudomonas aeruginosa is notable for its capacity to develop resistance to multiple antibiotic classes, and it is frequently associated with infections in patients with compromised immune systems.
C. difficile, meanwhile, is a spore-forming bacterium linked to antibiotic-associated diarrhoea and colitis. It spreads readily in healthcare environments and is tracked separately given its distinct transmission dynamics compared with bloodstream pathogens.
Ongoing Surveillance
The UKHSA's quarterly release cycle allows for the identification of seasonal patterns and longer-term trends in HCAI rates. By publishing this data as part of a structured, mandatory framework, the agency aims to support infection prevention efforts across the English healthcare system. Full statistical releases are made available via the UKHSA official statistics portal.